GlassScriptPhysician profile
Jennie Faber
NPI 1629079553
$6,336.37
in general payments reported to CMS, 2019-2025
34 companies · $915 in 2025
The $915 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $802 · 2020: $613 · 2021: $739 · 2022: $1,078 · 2023: $1,178 · 2024: $1,011 · 2025: $915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,912 · Education: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,912.05 |
| Education | $191.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $704.64 | 2019-2025 | |
| Astellas Pharma US INC | $699.41 | 2019-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $642.06 | 2021-2025 | |
| Exeltis, USA INC. | $556.53 | 2019-2025 | Slynd |
| Therapeuticsmd, INC. | $388.71 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $342.27 | 2019-2025 | |
| Pfizer INC. | $327.93 | 2019-2024 | |
| Sage Therapeutics, LLC | $306.69 | 2022-2025 | Zurzuvae |
| Coopersurgical, INC. | $246.83 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Millicent US INC | $201.74 | 2019-2024 | Femring, Intrarosa |
| Amgen INC. | $198.23 | 2019-2024 | Evenity, Prolia |
| Evofem Biosciences, INC. | $195.10 | 2020-2025 | Phexxi, Solosec, Phexx |
| Merck Sharp & Dohme LLC | $162.96 | 2019-2023 | Gardasil 9 |
| Hologic Sales and Service, LLC | $157.04 | 2019-2025 | Aptima, Coolseal Generator, Novasure |
| Aspira Women'S Health INC | $139.50 | 2021-2024 | Ova1 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $132.96 | 2021-2022 | |
| Shield Therapeutics INC | $110.72 | 2024-2025 | |
| Duchesnay USA Incorporated | $107.57 | 2019-2020 | |
| Organon LLC | $95.14 | 2022-2025 | Nexplanon |
| Amag Pharmaceuticals, INC. | $85.75 | 2019-2020 | |
| Allergan, INC. | $77.80 | 2019-2020 | |
| Avion Pharmaceuticals | $73.84 | 2019-2023 | Balcoltra |
| Dysis Medical, INC. | $62.21 | 2019 | |
| Mylan Pharmaceuticals INC. | $54.28 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $53.84 | 2025 | Qelbree |
| Sumitomo Pharma America, INC. | $47.66 | 2024-2025 | Gemtesa, Myfembree |
| Sanara Medtech INC. | $37.93 | 2022-2023 | Celleraterx |
| Heron Therapeutics, INC. | $25.62 | 2022 | |
| Roche Diagnostics Corporation | $20.36 | 2019 | |
| Medtronic, INC. | $19.76 | 2024 | Ligasure |
| Exact Sciences Corporation | $18.59 | 2023 | Cologuard Collection Kit |
| Mycovia Pharmaceuticals, INC. | $15.75 | 2023 | Vivjoa |
| Lupin INC. | $14.14 | 2019 | |
| Minerva Surgical, INC | $12.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennie Faber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.